These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 19204971

  • 1. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
    Toiyama Y, Miki C, Inoue Y, Kawamoto A, Kusunoki M.
    J Surg Oncol; 2009 May 01; 99(6):368-72. PubMed ID: 19204971
    [Abstract] [Full Text] [Related]

  • 2. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
    Yasuda H, Toiyama Y, Ohi M, Mohri Y, Miki C, Kusunoki M.
    J Surg Oncol; 2011 Jun 01; 103(7):695-9. PubMed ID: 21308684
    [Abstract] [Full Text] [Related]

  • 3. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
    Kurkijärvi R, Adams DH, Leino R, Möttönen T, Jalkanen S, Salmi M.
    J Immunol; 1998 Aug 01; 161(3):1549-57. PubMed ID: 9686623
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of serum soluble E-cadherin in colorectal carcinoma.
    Okugawa Y, Toiyama Y, Inoue Y, Iwata T, Fujikawa H, Saigusa S, Konishi N, Tanaka K, Uchida K, Kusunoki M.
    J Surg Res; 2012 Jun 15; 175(2):e67-73. PubMed ID: 22277332
    [Abstract] [Full Text] [Related]

  • 5. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL, Chang SC, Lin JK, Wang HS, Yang SH, Jiang JK, Chen WC, Lin TC.
    Hepatogastroenterology; 2005 Jun 15; 52(66):1688-91. PubMed ID: 16334758
    [Abstract] [Full Text] [Related]

  • 6. Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients.
    Toiyama Y, Miki C, Inoue Y, Okugawa Y, Koike Y, Yokoe T, Tanaka K, Kusunoki M.
    Ann Surg Oncol; 2008 Jun 15; 15(6):1617-24. PubMed ID: 18368454
    [Abstract] [Full Text] [Related]

  • 7. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M, Toiyama Y, Tanaka K, Saigusa S, Okugawa Y, Hiro J, Uchida K, Mohri Y, Inoue Y, Kusunoki M.
    Eur J Cancer; 2012 Sep 15; 48(14):2244-51. PubMed ID: 22197219
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer.
    Toiyama Y, Fujikawa H, Kawamura M, Matsushita K, Saigusa S, Tanaka K, Inoue Y, Uchida K, Mohri Y, Kusunoki M.
    Int J Oncol; 2012 Feb 15; 40(2):560-6. PubMed ID: 22038159
    [Abstract] [Full Text] [Related]

  • 9. Serum level of soluble vascular cell adhesion molecule 1 is a valuable prognostic marker in colorectal carcinoma.
    Okugawa Y, Miki C, Toiyama Y, Koike Y, Inoue Y, Kusunoki M.
    Dis Colon Rectum; 2009 Jul 15; 52(7):1330-6. PubMed ID: 19571712
    [Abstract] [Full Text] [Related]

  • 10. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K, Toiyama Y, Tanaka K, Saigusa S, Hiro J, Uchida K, Inoue Y, Kusunoki M.
    Ann Surg Oncol; 2012 Jul 15; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [Abstract] [Full Text] [Related]

  • 11. Human neutrophil peptides 1, 2 and 3 (HNP 1-3): elevated serum levels in colorectal cancer and novel marker of lymphatic and hepatic metastasis.
    Kemik O, Kemik AS, Sumer A, Begenik H, Purisa S, Tuzun S.
    Hum Exp Toxicol; 2013 Feb 15; 32(2):167-71. PubMed ID: 21669914
    [Abstract] [Full Text] [Related]

  • 12. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B, Groblewska M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B, Łaszewicz W, Dabrowski A, Szmitkowski M.
    Clin Chim Acta; 2007 May 01; 380(1-2):208-12. PubMed ID: 17368603
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T, Okada N, Ishibashi K, Ogata K, Ohsawa T, Ishiguro T, Nakada H, Yokoyama M, Matsuki M, Kato H, Kuwano H, Ishida H.
    Jpn J Clin Oncol; 2008 Dec 01; 38(12):839-43. PubMed ID: 18923001
    [Abstract] [Full Text] [Related]

  • 14. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H.
    Ann Surg Oncol; 2008 Dec 01; 15(12):3433-9. PubMed ID: 18846401
    [Abstract] [Full Text] [Related]

  • 15. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease.
    Kurkijärvi R, Yegutkin GG, Gunson BK, Jalkanen S, Salmi M, Adams DH.
    Gastroenterology; 2000 Oct 01; 119(4):1096-103. PubMed ID: 11040196
    [Abstract] [Full Text] [Related]

  • 16. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB.
    Acta Obstet Gynecol Scand; 2008 Oct 01; 87(11):1136-42. PubMed ID: 18951217
    [Abstract] [Full Text] [Related]

  • 17. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS, Wu TL, Tsao KC, Sun CF.
    Ann Clin Lab Sci; 2006 Oct 01; 36(1):23-30. PubMed ID: 16501233
    [Abstract] [Full Text] [Related]

  • 18. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes.
    Yoshikawa N, Noda K, Shinoda H, Uchida A, Ozawa Y, Tsubota K, Mashima Y, Ishida S.
    J Diabetes Complications; 2013 Oct 01; 27(2):162-6. PubMed ID: 23062326
    [Abstract] [Full Text] [Related]

  • 19. Soluble vascular adhesion protein-1: decreased activity in the plasma of trauma victims and predictive marker for severity of traumatic brain injury.
    Lin Z, Han M, Li H, Luo H, Zhang Y, Luo W.
    Clin Chim Acta; 2011 Aug 17; 412(17-18):1678-82. PubMed ID: 21645499
    [Abstract] [Full Text] [Related]

  • 20. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K, Yamashita K, Hirai K, Kumamoto H, Sato T, Ozawa H, Nakamura T, Onozato W, Kokuba Y, Ihara A, Watanabe M.
    Oncol Rep; 2008 Oct 17; 20(4):737-43. PubMed ID: 18813812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.